Stocks · NYSE · Healthcare · United States
TMO — Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. (TMO) is a healthcare stock listed on NYSE (United States). At the close of September 29, 2026 it traded at 679.61 (+0.15% on the day), +10.2% over one month, +32.5% over three months, +47.6% over twelve months. The InvestMuse composite score is +18 on a −100 to +100 scale, a mixed read that ranks #555 of about 1,221 assets. The strongest of its nine dimensions are Trend (+86) and Momentum (+69); the weakest is Regime (hidden Markov model) (-60). Its volatility regime from the hidden Markov model is Cool. 67 news articles in the last 30 days carried an average tone of +0.31 (on −1 to +1).
The facts
| Last close | 679.61 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | +0.15% / +10.2% / +32.5% / +47.6% |
| 52-week range | 437.57 – 679.61 |
| Composite score | +18 / 100 · mixed view · rank #555 |
| Volatility regime (HMM) | Cool |
| Resistance levels | 525.00, 595.00 |
| Trailing P/E | 26.7 |
| Market cap | $186.0B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)-60
- Technical indicators-32
- Trend+86
- Support / resistance0
- Fundamentals+58
- Sector edge+3
- News sentiment+33
- Momentum+69
- Chart patterns and zones+20
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.